IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Salix Pharmaceuticals Inc

CUSIP: 795435AE6 | 107 institutional holders

Quarters

Q4 2018Q3 2018Q2 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2018

Cribstone Capital Management, LLC2,000
0.0% of portfolio›$5
StyleTurnoverLocationFiled
Cribstone Capital Management, LLC
2,000$50.0%N/AN/AAugusta, ME2019-02-12